| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Functional Enrichment of GO Terms in CellAge genes (for comparison) | ElasticNet CellAge vs non-CellAge Classifier | ElasticNet Senescense Promoter vs. Inhibitor Classifier | |||||||||||||||||||||||
2 | AUC 0.82 | AUC 0.66 | ||||||||||||||||||||||||
3 | Background geneset: All human protein-coding genes from NCBI (18,400) | Label: Is gene in CellAge? | Label: does gene promote senescence? | |||||||||||||||||||||||
4 | Study genes: All genes in CellAge (279) | Features: length 17,506 binary vector encoding GO terms for gene | Features: length 17,506 binary vector encoding GO terms for gene | |||||||||||||||||||||||
5 | Included genes: all human genes from NCBI gene2go (19,238) | Included genes: all CellAge genes that either promote or inhibit senescence (272) | ||||||||||||||||||||||||
6 | Grouped by GO namespace, sorted by FDR-adjusted p-value within each group | Grouped by GO namespace, GO Term coefficients in model sorted by abs(coefficient) | Grouped by GO namespace, GO Term coefficients in model sorted by abs(coefficient) | |||||||||||||||||||||||
7 | id | p-value | enrichment | cellage_count | ns | name | id | coefficient | ns | name | id | coefficient | ns | name | ||||||||||||
8 | GO:0000122 | 4.57E-24 | 5.69791 | 58 | BP | negative regulation of transcription from RNA polymerase II promoter | GO:0008285 | 0.731192 | BP | negative regulation of cell proliferation | GO:0051301 | -0.658073 | BP | cell division | ||||||||||||
9 | GO:0045944 | 1.30E-23 | 4.779866 | 66 | BP | positive regulation of transcription from RNA polymerase II promoter | GO:0000122 | 0.587924 | BP | negative regulation of transcription from RNA polymerase II promoter | GO:0008285 | 0.526409 | BP | negative regulation of cell proliferation | ||||||||||||
10 | GO:0006468 | 1.49E-21 | 7.375631 | 43 | BP | protein phosphorylation | GO:0006468 | 0.483493 | BP | protein phosphorylation | GO:0006355 | 0.451376 | BP | regulation of transcription, DNA-templated | ||||||||||||
11 | GO:0008285 | 1.47E-19 | 7.457456 | 39 | BP | negative regulation of cell proliferation | GO:0045944 | 0.412141 | BP | positive regulation of transcription from RNA polymerase II promoter | GO:0016310 | 0.44867 | BP | phosphorylation | ||||||||||||
12 | GO:0045893 | 8.64E-18 | 6.031022 | 42 | BP | positive regulation of transcription, DNA-templated | GO:0045892 | 0.283067 | BP | negative regulation of transcription, DNA-templated | GO:0007265 | 0.435431 | BP | Ras protein signal transduction | ||||||||||||
13 | GO:0045892 | 1.73E-16 | 6.077594 | 39 | BP | negative regulation of transcription, DNA-templated | GO:0007165 | 0.242178 | BP | signal transduction | GO:0055114 | -0.398245 | BP | oxidation-reduction process | ||||||||||||
14 | GO:0007050 | 2.78E-12 | 10.863332 | 20 | BP | cell cycle arrest | GO:0016055 | 0.224283 | BP | Wnt signaling pathway | GO:0007050 | 0.396757 | BP | cell cycle arrest | ||||||||||||
15 | GO:0018105 | 7.95E-12 | 10.268081 | 20 | BP | peptidyl-serine phosphorylation | GO:0007050 | 0.219356 | BP | cell cycle arrest | GO:0006950 | -0.393269 | BP | response to stress | ||||||||||||
16 | GO:0006366 | 1.04E-10 | 4.484606 | 35 | BP | transcription from RNA polymerase II promoter | GO:0007568 | 0.217997 | BP | aging | GO:0009314 | -0.382655 | BP | response to radiation | ||||||||||||
17 | GO:0090398 | 1.30E-10 | 32.589995 | 10 | BP | cellular senescence | GO:0006351 | -0.207884 | BP | transcription, DNA-templated | GO:0006936 | -0.378022 | BP | muscle contraction | ||||||||||||
18 | GO:0090399 | 3.56E-10 | 49.971326 | 8 | BP | replicative senescence | GO:0006355 | -0.204351 | BP | regulation of transcription, DNA-templated | GO:0050790 | -0.372019 | BP | regulation of catalytic activity | ||||||||||||
19 | GO:0042981 | 1.12E-09 | 6.871057 | 22 | BP | regulation of apoptotic process | GO:0090399 | 0.195589 | BP | replicative senescence | GO:0007186 | 0.362351 | BP | G-protein coupled receptor signaling pathway | ||||||||||||
20 | GO:0007346 | 2.54E-09 | 12.955529 | 14 | BP | regulation of mitotic cell cycle | GO:0045893 | 0.186276 | BP | positive regulation of transcription, DNA-templated | GO:0006508 | -0.358778 | BP | proteolysis | ||||||||||||
21 | GO:0006974 | 5.00E-09 | 7.172918 | 20 | BP | cellular response to DNA damage stimulus | GO:0006695 | 0.176047 | BP | cholesterol biosynthetic process | GO:0008284 | -0.34835 | BP | positive regulation of cell proliferation | ||||||||||||
22 | GO:0043066 | 5.27E-09 | 4.634867 | 29 | BP | negative regulation of apoptotic process | GO:0007155 | 0.164915 | BP | cell adhesion | GO:0006457 | -0.345861 | BP | protein folding | ||||||||||||
23 | GO:0010628 | 2.85E-08 | 5.786154 | 22 | BP | positive regulation of gene expression | GO:0010628 | 0.16448 | BP | positive regulation of gene expression | GO:0006468 | 0.336667 | BP | protein phosphorylation | ||||||||||||
24 | GO:0048146 | 3.49E-08 | 16.167194 | 11 | BP | positive regulation of fibroblast proliferation | GO:0043066 | 0.163954 | BP | negative regulation of apoptotic process | GO:0000086 | -0.330245 | BP | G2/M transition of mitotic cell cycle | ||||||||||||
25 | GO:1901796 | 1.73E-07 | 8.453796 | 15 | BP | regulation of signal transduction by p53 class mediator | GO:0045766 | 0.159395 | BP | positive regulation of angiogenesis | GO:0045892 | -0.327497 | BP | negative regulation of transcription, DNA-templated | ||||||||||||
26 | GO:0006338 | 3.57E-07 | 11.243548 | 12 | BP | chromatin remodeling | GO:0043547 | -0.154076 | BP | positive regulation of GTPase activity | GO:0060337 | 0.307964 | BP | type I interferon signaling pathway | ||||||||||||
27 | GO:0006978 | 3.69E-07 | 32.793683 | 7 | BP | DNA damage response, signal transduction by p53 class mediator resulting in ... | GO:0000209 | 0.148077 | BP | protein polyubiquitination | GO:0048146 | -0.29871 | BP | positive regulation of fibroblast proliferation | ||||||||||||
28 | GO:0007569 | 3.91E-07 | 23.986237 | 8 | BP | cell aging | GO:0008283 | 0.137105 | BP | cell proliferation | GO:0006357 | -0.297354 | BP | regulation of transcription from RNA polymerase II promoter | ||||||||||||
29 | GO:2000772 | 4.80E-07 | 44.974194 | 6 | BP | regulation of cellular senescence | GO:0048146 | 0.133367 | BP | positive regulation of fibroblast proliferation | GO:0034220 | -0.295278 | BP | ion transmembrane transport | ||||||||||||
30 | GO:0071456 | 6.23E-07 | 9.280389 | 13 | BP | cellular response to hypoxia | GO:0006928 | 0.127235 | BP | movement of cell or subcellular component | GO:0043687 | 0.292479 | BP | post-translational protein modification | ||||||||||||
31 | GO:0035897 | 9.59E-07 | 62.464158 | 5 | BP | proteolysis in other organism | GO:0001558 | 0.124158 | BP | regulation of cell growth | GO:0046777 | -0.291612 | BP | protein autophosphorylation | ||||||||||||
32 | GO:0008283 | 1.06E-06 | 4.645222 | 22 | BP | cell proliferation | GO:0018105 | 0.121789 | BP | peptidyl-serine phosphorylation | GO:0045893 | 0.290134 | BP | positive regulation of transcription, DNA-templated | ||||||||||||
33 | GO:0070301 | 2.04E-06 | 12.704574 | 10 | BP | cellular response to hydrogen peroxide | GO:0001649 | 0.117478 | BP | osteoblast differentiation | GO:0006351 | 0.289748 | BP | transcription, DNA-templated | ||||||||||||
34 | GO:0010629 | 2.59E-06 | 7.390126 | 14 | BP | negative regulation of gene expression | GO:2000772 | 0.116986 | BP | regulation of cellular senescence | GO:0007420 | -0.285442 | BP | brain development | ||||||||||||
35 | GO:0043065 | 2.67E-06 | 4.835935 | 20 | BP | positive regulation of apoptotic process | GO:0071456 | 0.112651 | BP | cellular response to hypoxia | GO:0042981 | -0.279535 | BP | regulation of apoptotic process | ||||||||||||
36 | GO:0006977 | 3.09E-06 | 12.089837 | 10 | BP | DNA damage response, signal transduction by p53 class mediator resulting in ... | GO:0016569 | 0.103492 | BP | covalent chromatin modification | GO:0051607 | 0.278614 | BP | defense response to virus | ||||||||||||
37 | GO:0000165 | 6.81E-06 | 5.072277 | 18 | BP | MAPK cascade | GO:0016021 | -0.824735 | CC | integral component of membrane | GO:0031648 | -0.267268 | BP | protein destabilization | ||||||||||||
38 | GO:0090400 | 1.00E-05 | 74.956989 | 4 | BP | stress-induced premature senescence | GO:0005654 | 0.465936 | CC | nucleoplasm | GO:0016020 | -0.851689 | CC | membrane | ||||||||||||
39 | GO:0071480 | 1.17E-05 | 20.180728 | 7 | BP | cellular response to gamma radiation | GO:0005634 | 0.340402 | CC | nucleus | GO:0005654 | -0.770552 | CC | nucleoplasm | ||||||||||||
40 | GO:0045766 | 1.17E-05 | 7.960034 | 12 | BP | positive regulation of angiogenesis | GO:0005622 | 0.334649 | CC | intracellular | GO:0000139 | 0.457541 | CC | Golgi membrane | ||||||||||||
41 | GO:0006915 | 1.68E-05 | 3.529048 | 25 | BP | apoptotic process | GO:0005887 | -0.230329 | CC | integral component of plasma membrane | GO:0005622 | 0.402078 | CC | intracellular | ||||||||||||
42 | GO:0005654 | 1.56E-35 | 3.270941 | 131 | CC | nucleoplasm | GO:0005743 | -0.146594 | CC | mitochondrial inner membrane | GO:0016363 | 0.370372 | CC | nuclear matrix | ||||||||||||
43 | GO:0000790 | 3.16E-06 | 6.118938 | 16 | CC | nuclear chromatin | GO:0005829 | 0.132199 | CC | cytosol | GO:0005737 | 0.363262 | CC | cytoplasm | ||||||||||||
44 | GO:0004674 | 4.13E-25 | 9.156678 | 43 | MF | protein serine/threonine kinase activity | GO:0005874 | -0.120571 | CC | microtubule | GO:0005813 | -0.341483 | CC | centrosome | ||||||||||||
45 | GO:0005524 | 4.81E-21 | 3.807012 | 74 | MF | ATP binding | GO:1904813 | 0.116227 | CC | ficolin-1-rich granule lumen | GO:0043234 | 0.333034 | CC | protein complex | ||||||||||||
46 | GO:0003682 | 5.29E-13 | 6.246416 | 31 | MF | chromatin binding | GO:0004674 | 0.491604 | MF | protein serine/threonine kinase activity | GO:0000922 | -0.312119 | CC | spindle pole | ||||||||||||
47 | GO:0019901 | 1.84E-11 | 5.664256 | 30 | MF | protein kinase binding | GO:0005524 | 0.417341 | MF | ATP binding | GO:0005524 | 0.659829 | MF | ATP binding | ||||||||||||
48 | GO:0004672 | 9.29E-11 | 8.372855 | 21 | MF | protein kinase activity | GO:0003682 | 0.271371 | MF | chromatin binding | GO:0003700 | 0.447218 | MF | transcription factor activity, sequence-specific DNA binding | ||||||||||||
49 | GO:0008134 | 3.15E-08 | 5.745832 | 22 | MF | transcription factor binding | GO:0005525 | -0.243392 | MF | GTP binding | GO:0001085 | 0.385389 | MF | RNA polymerase II transcription factor binding | ||||||||||||
50 | GO:0044212 | 3.49E-08 | 6.814272 | 19 | MF | transcription regulatory region DNA binding | GO:0045296 | 0.237482 | MF | cadherin binding | GO:0003677 | 0.37678 | MF | DNA binding | ||||||||||||
51 | GO:0004708 | 2.23E-07 | 34.979928 | 7 | MF | MAP kinase kinase activity | GO:0019901 | 0.235988 | MF | protein kinase binding | GO:0019901 | 0.343389 | MF | protein kinase binding | ||||||||||||
52 | GO:0003700 | 4.71E-07 | 3.234889 | 35 | MF | transcription factor activity, sequence-specific DNA binding | GO:0046872 | -0.219303 | MF | metal ion binding | GO:0042803 | -0.343368 | MF | protein homodimerization activity | ||||||||||||
53 | GO:0019899 | 4.78E-07 | 4.893335 | 22 | MF | enzyme binding | GO:0031994 | 0.172835 | MF | insulin-like growth factor I binding | GO:0002039 | 0.327408 | MF | p53 binding | ||||||||||||
54 | GO:0003714 | 5.87E-07 | 6.46837 | 17 | MF | transcription corepressor activity | GO:0004930 | -0.136012 | MF | G-protein coupled receptor activity | GO:0005515 | -0.308268 | MF | protein binding | ||||||||||||
55 | GO:0002039 | 8.55E-07 | 11.778955 | 11 | MF | p53 binding | GO:0003779 | -0.123382 | MF | actin binding | GO:0031490 | -0.287917 | MF | chromatin DNA binding | ||||||||||||
56 | GO:0001077 | 2.06E-06 | 5.197747 | 19 | MF | transcriptional activator activity, RNA polymerase II core promoter proximal... | GO:0005509 | -0.118694 | MF | calcium ion binding | GO:0004674 | 0.283053 | MF | protein serine/threonine kinase activity | ||||||||||||
57 | GO:0004713 | 3.23E-06 | 7.98722 | 13 | MF | protein tyrosine kinase activity | GO:0004713 | 0.116005 | MF | protein tyrosine kinase activity | GO:0045296 | -0.273407 | MF | cadherin binding | ||||||||||||
58 | ||||||||||||||||||||||||||
59 | ||||||||||||||||||||||||||
60 | ||||||||||||||||||||||||||
61 | ||||||||||||||||||||||||||
62 | ||||||||||||||||||||||||||
63 | ||||||||||||||||||||||||||
64 | ||||||||||||||||||||||||||
65 | ||||||||||||||||||||||||||
66 | ||||||||||||||||||||||||||
67 | ||||||||||||||||||||||||||
68 | ||||||||||||||||||||||||||
69 | ||||||||||||||||||||||||||
70 | ||||||||||||||||||||||||||
71 | ||||||||||||||||||||||||||
72 | ||||||||||||||||||||||||||
73 | ||||||||||||||||||||||||||
74 | ||||||||||||||||||||||||||
75 | ||||||||||||||||||||||||||
76 | ||||||||||||||||||||||||||
77 | ||||||||||||||||||||||||||
78 | ||||||||||||||||||||||||||
79 | ||||||||||||||||||||||||||
80 | ||||||||||||||||||||||||||
81 | ||||||||||||||||||||||||||
82 | ||||||||||||||||||||||||||
83 | ||||||||||||||||||||||||||
84 | ||||||||||||||||||||||||||
85 | ||||||||||||||||||||||||||
86 | ||||||||||||||||||||||||||
87 | ||||||||||||||||||||||||||
88 | ||||||||||||||||||||||||||
89 | ||||||||||||||||||||||||||
90 | ||||||||||||||||||||||||||
91 | ||||||||||||||||||||||||||
92 | ||||||||||||||||||||||||||
93 | ||||||||||||||||||||||||||
94 | ||||||||||||||||||||||||||
95 | ||||||||||||||||||||||||||
96 | ||||||||||||||||||||||||||
97 | ||||||||||||||||||||||||||
98 | ||||||||||||||||||||||||||
99 | ||||||||||||||||||||||||||
100 |